| Document title | PUC: General category | PUC: Family | PUC: Type |
|---|---|---|---|
| 04507 RHEUMATREX METHOTREXATE SODIUM TABLETS 2.5 MG | Food and drug | pharmaceuticals | - |
| 04561 METHOTREXATE SODIUM TABLETS 2.5 MG | Food and drug | pharmaceuticals | - |
| 04572 METHOTREXATE SODIUM TABLETS 10 MG | Food and drug | pharmaceuticals | - |
| 04652/04653 METHOTREXATE PARENTERAL LOW SODIUM 500MG/1G/VIAL | Food and drug | pharmaceuticals | - |
| 04654 METHOTREXATE PARENTERAL LOW SODIUM 20 MG/VIAL | Food and drug | pharmaceuticals | - |
| 09337 METHOTREXATE PARENTERAL LOW SODIUM 50 MG/VIAL | Food and drug | pharmaceuticals | - |
| 41400 METHOTREXATE 500 MG | Food and drug | pharmaceuticals | - |
| METHOTREXATE SODIUM FOR INJECTION | Food and drug | pharmaceuticals | - |
| METHOTREXATE SODIUM INJECTION | Food and drug | pharmaceuticals | - |
| METHOTREXATE SODIUM INJECTION, 50 MG/ VIAL, (04556) | Food and drug | pharmaceuticals | - |
| METHOTREXATE SODIUM INJECTION, USP | Food and drug | pharmaceuticals | - |
| METHOTREXATE SODIUM INJECTION,USP | Food and drug | pharmaceuticals | - |
| METHOTREXATE USP | Food and drug | pharmaceuticals | - |
| METHOTREXATE; NDC00005-4507-23 | Food and drug | pharmaceuticals | - |
| NDC00205-5325-26 METHOTREXATE SODIUM INJECTION | Food and drug | pharmaceuticals | - |
| NDC00205-5327-30 METHOTREXATE SODIUM INJECTION | Food and drug | pharmaceuticals | - |
We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.